High Versus Normal Blood Pressure Targets in Relation to Right Ventricular Dysfunction After Cardiac Surgery: A...

Area of Science:

• Cardiology
• Critical Care Medicine
• Cardiac Surgery

Background:

• Right ventricular (RV) dysfunction management is challenging, often relying on blood pressure augmentation.
• Current evidence lacks robust clinical data on the efficacy of blood pressure targets in cardiac surgery patients with RV dysfunction.

Purpose of the Study:

• To evaluate the effectiveness of higher mean arterial pressure targets in improving RV ejection fraction (RVEF) in patients undergoing cardiac surgery.
• To compare the impact of normal versus high blood pressure targets on RV function post-cardiac surgery.

Main Methods:

• A randomized controlled trial was conducted with 78 patients with pulmonary artery catheters (PAC) and varying degrees of RV dysfunction.
• Patients were assigned to either a normal (65 mmHg) or high (85 mmHg) mean arterial pressure target group.
• The primary endpoint was the change in PAC-derived RVEF over a one-hour period.

Main Results:

• No significant difference in the change of RVEF was observed between the normal and high blood pressure target groups for patients with RVEF <20% (p=0.159).
• Similarly, no significant difference in RVEF change was found for patients with RVEF between 20%-30% (p=0.074).
• Echocardiographic variables of RV and left ventricular function remained unaltered regardless of baseline RVEF or treatment protocol.

Conclusions:

• In cardiac surgery patients with RV dysfunction, targeting higher mean arterial pressure with norepinephrine did not enhance PAC-derived RVEF compared to normal blood pressure targets.
• The findings suggest that current strategies of blood pressure augmentation may not be effective for improving RV function in this clinical setting.